Abeona Therapeutics Inc. (ABEO) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ABEO Revenue Growth
Revenue Breakdown (FY 2025)
ABEO's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
ABEO Revenue Analysis (2014–2025)
As of May 8, 2026, Abeona Therapeutics Inc. (ABEO) generated trailing twelve-month (TTM) revenue of $5.8 million. The most recent quarter (Q4 2025) recorded $5.4 million in revenue.
Looking at the longer-term picture, ABEO's 5-year compound annual growth rate (CAGR) stands at -10.3%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $10.0 million in 2020.
Revenue diversification analysis shows ABEO's business is primarily driven by License (58%), and Product (42%). With over half of revenue concentrated in License, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including KRYS (+25.1% YoY), RARE (+13.3% YoY), and FOLD (+20.0% YoY). Compare ABEO vs KRYS →
ABEO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ABEOCurrent | $6M | - | -10.3% | -1536.9% | |
 KRYS | $389M | +25.1% | - | 41.5% | |
 RARE | $673M | +13.3% | +19.9% | -79.5% | |
 FOLD | $634M | +20.0% | +19.4% | 5.4% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% |
ABEO Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5.8M | - | $4.3M | 73.7% | $-89,448,000 | -1536.9% |
| 2024 | $0 | -100.0% | $-2,907,000 | - | $-64,211,000 | - |
| 2023 | $3.5M | +147.5% | $1.9M | 54.1% | $-47,135,000 | -1346.7% |
| 2022 | $1.4M | -52.9% | $964K | 68.2% | $-50,915,000 | -3600.8% |
| 2021 | $3.0M | -70.0% | $3.0M | 100.0% | $-89,836,000 | -2994.5% |
| 2020 | $10.0M | - | $10.0M | 100.0% | $-81,420,000 | -814.2% |
| 2019 | $0 | -100.0% | $-48,566,000 | - | $-77,090,000 | - |
| 2018 | $3.0M | +258.2% | $-35,700,000 | -1190.8% | $-58,166,000 | -1940.2% |
| 2017 | $837K | -5.8% | $-16,152,000 | -1929.7% | $-27,836,000 | -3325.7% |
| 2016 | $889K | -14.5% | $-9,766,000 | -1098.5% | $-23,881,000 | -2686.3% |
See ABEO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ABEO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ABEO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonABEO — Frequently Asked Questions
Quick answers to the most common questions about buying ABEO stock.
Is ABEO's revenue growth accelerating or slowing?
ABEO TTM revenue: $6M. YoY growth: N/A. 5-year CAGR: -10.3%.
What is ABEO's long-term revenue growth rate?
Abeona Therapeutics Inc.'s 5-year revenue CAGR of -10.3% reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is ABEO's revenue distributed by segment?
ABEO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.